Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.8 USD | -1.93% | -11.12% | +3.88% |
May. 09 | Masimo says prepared to provide one board seat to activist investor Politan | RE |
May. 09 | Masimo Corporation Craig Reynolds Sends a Letter to Politan Capital's Quentin Koffey | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 66.63 and 40.94 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.88% | 6.46B | C- | ||
+73.46% | 12.41B | B- | ||
-15.61% | 8.23B | C+ | ||
+14.69% | 5.5B | D+ | ||
+42.58% | 5.1B | - | ||
-19.05% | 4.05B | B- | ||
-32.61% | 2.54B | C | ||
-0.74% | 1.99B | - | ||
+10.80% | 1.99B | - | ||
+10.31% | 1.77B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MASI Stock
- Ratings Masimo Corporation